REV 5901 is a competitive and orally effective leukotriene receptor antagonist (Ki of 0.7 µM) and a 5-lipoxygenase inhibitor, suitable for research on asthma involving leukotriene release [1] [2].
Molecular Weight:
335.44
CAS Number:
[101910-24-1]
Formula:
C22H25NO2
Target:
Lipoxygenase|||Leukotriene Receptor|||Others
T21821
* VAT and and shipping costs not included. Errors and price changes excepted